Coya Therapeutics, Inc.
COYA- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001835022
No open-market purchases or sales by Coya Therapeutics, Inc. insiders were filed in the last 90 days; 54 institutions reported holding it in 13F filings for Q2 2026, worth $45.5M in total; Greenlight Capital is the only superinvestor holding it.
Superinvestors holding COYA, Q2 2026
1 superinvestor reports holding Coya Therapeutics, Inc. on Form 13F, worth $13.7M in total. Weight is Coya Therapeutics, Inc.'s share of each 13F portfolio; actions compare shares with Q1 2026.
| Superinvestor | % of portfolio | Shares | Value | vs. previous quarter |
|---|---|---|---|---|
| Greenlight CapitalDavid Einhorn | 0.3% | 2,335,540 | $13.7M | Unchanged |
Moves by quarter
Superinvestors that opened, added to, trimmed or sold out of COYA each quarter, comparing shares with the quarter before. A superinvestor that didn't file for a quarter isn't listed, and isn't counted as selling.
Q1 2026
1 superinvestor holding at quarter end
- Added
- Greenlight Capital (+15.3%)
Q4 2025
1 superinvestor holding at quarter end
- Added
- Greenlight Capital (+23.0%)
Q4 2024
1 superinvestor holding at quarter end
- Added
- Greenlight Capital (+29.2%)
Q4 2023
1 superinvestor holding at quarter end
- Added
- Greenlight Capital (+172.2%)
Q3 2023
1 superinvestor holding at quarter end
- Added
- Greenlight Capital (+19.2%)
Q1 2023
1 superinvestor holding at quarter end
- Added
- Greenlight Capital (+0.1%)
Q4 2022
1 superinvestor holding at quarter end